A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2013

Study Completion Date

February 28, 2014

Conditions
Acute Ischemic Stroke
Interventions
BIOLOGICAL

Plasmin (Human)

Plasmin (Human), 20 mg, delivered through a catheter into a thrombus

BIOLOGICAL

Plasmin (Human)

Plasmin (Human), 40 mg, delivered through a catheter into a thrombus

BIOLOGICAL

Plasmin (Human)

Plasmin (Human), 80 mg, delivered through a catheter into a thrombus

Trial Locations (23)

3050

Royal Melbourne Hospital, Parkville

3084

Heidelberg Repatriation Hospital, Melbourne, Heidelberg

4020

O.O. Landes-Nervenklinik Wagner-Jauregg, Linz

5020

Christian-Doppler-Klinik Salzburg,Universitätsklinik für Neurologie, Salzburg

11000

Clinical Center of Serbia, Clinic for Vascular and Endovascular Surgery, Belgrade

"Special Hospital for Cerebrovascular Diseases Sveti Sava", Belgrade

18000

Clinical Center Niš, Center of Radiology, Niš

21000

Clinical Center of Vojvodina, Center for Radiology, Novi Sad

28007

Hospital General Universitario Gregorio Marañon, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

31059

Hôpital Rangueil, Toulouse

34000

Clinical Center Kragujevac, Center for Radiology Diagnostic, Kragujevac

34295

Hôpital Gui de Chauliac, Montpellier

63003

Hôpital Gabriel Montpied, Clermont-Ferrand

75877

Hôpital Bichat-Claude Bernard, Paris

95001

Neurology Clinic, Faculty Hospital Nitra, Nitra

97517

Neurology Clinic Hospital with Policlinic of F.D. Roosevelt, Banská Bystrica

813 69

I. Neurology Clinic, University Hospital Bratislava, Bratislava

03659

Radiology Clinic, University Hospital Martin, Martin

036 26

Neurology Clinic, Central Military Faculty Hospital, Ružomberok

08907

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

08916

Hospital Universitario Germans Trias i Pujol, Badalona

08035

Hospital General Vall d'Hebron, Barcelona, Barcelona

Sponsors
All Listed Sponsors
lead

Grifols Therapeutics LLC

INDUSTRY